HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

(6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-6H-dibenzo(b,d)pyran-1-ol

HCID 10248110
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
628263-22-9
Standard SMILES
CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccccc3)cc1OC2(C)C
InChIKey
GZYXCXRHVALIJD-WOJBJXKFSA-N
Molecular formula
C25H30O2
Average molar mass
362.5 g/mol
Monoisotopic mass
362.2245802

Overview

used for the treatment of high-grade glioma; structure in first source

Names & identifiers

Preferred name
(6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-6H-dibenzo(b,d)pyran-1-ol
IUPAC
(6aR,10aR)-6,6,9-trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
English name
KM 233
Molecular formula
C25H30O2
Molecular weight
362.5

Names & synonyms

KM-233628263-22-9KM233YMV7S3C3B7DTXSID50745439(6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-6H-dibenzo(b,d)pyran-1-ol(6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-6H-dibenzo[b,d]pyran-1-olRefChem:906246DTXCID40696183(6aR,10aR)-6,6,9-Trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-olKM 233CHEMBL119592
Show more names
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-, (6aR,10aR)-
797793-15-8BAJ4486BWXSCHEMBL14447597SCHEMBL29738735GLXC-05626BDBM50133546NSC792739AKOS040745948

Database identifiers

CAS
628263-22-9、797793-15-8

Properties

Computed structural properties

XLogP
6.1
Topological polar surface area
29.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
27
Formal charge
0
Complexity
569

Physicochemical properties

storage temp.
-20 °C · Store at -20°C
solubility
30 mg/ml; · DMF: 30 mg/ml; DMF:PBS(pH7.2) (1:2): 0.3 mg/ml; DMSO: 20 mg/ml; Ethanol: 3 mg/ml
form
A crystalline solid
FDA UNII
7 S3C3B7 · YMV7S3C3B7

Chemistry & industry

Applications · 1 item

UsesBecause selective activation of peripheral cannabinoid (CB2) receptors in rat C-6 glioma cells has been shown to induce apoptosis through enhanced ceramide synthesis de novo, CB2 agonists present potential as anti glioma agents. KM 233 is a Δ8-tetrahydrocannabinol analog with a dimethyl substitution that exhibits high binding affinity for both the CB1 and CB2 receptors with 13-fold selectivity for the CB2 receptor (Kis = 12.3 and 0.91 nM, respectively). Demonstrating good lipophilicity and ability to penetrate the blood brain barrier, KM 233 inhibits human U87 glioma cell proliferation in vitro with an IC50 value of 1.4 μM and significantly reduces U87 glioma tumor size in vivo at a dose of 2 mg/kg in a SCID mouse xenograft side-pocket model.[Cayman Chemical]

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
PubChem CID
10248110
ChEMBL
CHEMBL119592
UNII
BAJ4486BWX、YMV7S3C3B7
Nikkaji
J2.025.101H